Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
About BBC News
This author has not written his bio yet.
But we are proud to say that BBC News contributed 3230 entries already.
This author has not written his bio yet.
But we are proud to say that BBC News contributed 3230 entries already.
